Dudediligence.

DBV Technologies S.A.

DBVTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$5.0Mlast 12 months
Net income
−$176.0Mlast 12 months
Operating cash flow
−$150.6Mlast 12 months
Cash and equivalents
$174.9Mat the last balance sheet
Shares outstanding
296.1M shareson issue
Every year and quarter →